Literature DB >> 25981301

Opioid receptors: Structural and mechanistic insights into pharmacology and signaling.

Yi Shang1, Marta Filizola2.   

Abstract

Opioid receptors are important drug targets for pain management, addiction, and mood disorders. Although substantial research on these important subtypes of G protein-coupled receptors has been conducted over the past two decades to discover ligands with higher specificity and diminished side effects, currently used opioid therapeutics remain suboptimal. Luckily, recent advances in structural biology of opioid receptors provide unprecedented insights into opioid receptor pharmacology and signaling. We review here a few recent studies that have used the crystal structures of opioid receptors as a basis for revealing mechanistic details of signal transduction mediated by these receptors, and for the purpose of drug discovery.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Allosteric modulators; Dimerization; Functional selectivity; GPCRs; Molecular dynamics; Opioid binding; Receptor; Virtual screening

Mesh:

Substances:

Year:  2015        PMID: 25981301      PMCID: PMC4584181          DOI: 10.1016/j.ejphar.2015.05.012

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  98 in total

1.  The therapeutic potential of κ-opioids for treatment of pain and addiction.

Authors:  Charles Chavkin
Journal:  Neuropsychopharmacology       Date:  2011-01       Impact factor: 7.853

Review 2.  Mu opioids and their receptors: evolution of a concept.

Authors:  Gavril W Pasternak; Ying-Xian Pan
Journal:  Pharmacol Rev       Date:  2013-09-27       Impact factor: 25.468

3.  Chemotype-selective modes of action of κ-opioid receptor agonists.

Authors:  Eyal Vardy; Philip D Mosier; Kevin J Frankowski; Huixian Wu; Vsevolod Katritch; Richard B Westkaemper; Jeffrey Aubé; Raymond C Stevens; Bryan L Roth
Journal:  J Biol Chem       Date:  2013-10-11       Impact factor: 5.157

4.  Identification of novel functionally selective κ-opioid receptor scaffolds.

Authors:  Kate L White; Alex P Scopton; Marie-Laure Rives; Ruslan V Bikbulatov; Prabhakar R Polepally; Peter J Brown; Terrance Kenakin; Jonathan A Javitch; Jordan K Zjawiony; Bryan L Roth
Journal:  Mol Pharmacol       Date:  2013-10-10       Impact factor: 4.436

Review 5.  Novel GPCR paradigms at the μ-opioid receptor.

Authors:  G L Thompson; E Kelly; A Christopoulos; M Canals
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

Review 6.  Revolution in GPCR signalling: opioid receptor heteromers as novel therapeutic targets: IUPHAR review 10.

Authors:  Wakako Fujita; Ivone Gomes; Lakshmi A Devi
Journal:  Br J Pharmacol       Date:  2014-09       Impact factor: 8.739

7.  Structure of a class C GPCR metabotropic glutamate receptor 1 bound to an allosteric modulator.

Authors:  Huixian Wu; Chong Wang; Karen J Gregory; Gye Won Han; Hyekyung P Cho; Yan Xia; Colleen M Niswender; Vsevolod Katritch; Jens Meiler; Vadim Cherezov; P Jeffrey Conn; Raymond C Stevens
Journal:  Science       Date:  2014-03-06       Impact factor: 47.728

Review 8.  Opiate addiction and cocaine addiction: underlying molecular neurobiology and genetics.

Authors:  Mary Jeanne Kreek; Orna Levran; Brian Reed; Stefan D Schlussman; Yan Zhou; Eduardo R Butelman
Journal:  J Clin Invest       Date:  2012-10-01       Impact factor: 14.808

9.  Morphine-like opiates selectively antagonize receptor-arrestin interactions.

Authors:  Paola Molinari; Vanessa Vezzi; Maria Sbraccia; Cristina Grò; Daniela Riitano; Caterina Ambrosio; Ida Casella; Tommaso Costa
Journal:  J Biol Chem       Date:  2010-02-26       Impact factor: 5.157

10.  Morphine side effects in beta-arrestin 2 knockout mice.

Authors:  Kirsten M Raehal; Julia K L Walker; Laura M Bohn
Journal:  J Pharmacol Exp Ther       Date:  2005-05-25       Impact factor: 4.030

View more
  24 in total

1.  Allosterism within δ Opioid-κ Opioid Receptor Heteromers in Peripheral Sensory Neurons: Regulation of κ Opioid Agonist Efficacy.

Authors:  Blaine A Jacobs; Miryam M Pando; Elaine Jennings; Teresa A Chavera; William P Clarke; Kelly A Berg
Journal:  Mol Pharmacol       Date:  2018-02-07       Impact factor: 4.436

2.  Selective opioid growth factor receptor antagonists based on a stilbene isostere.

Authors:  David P Stockdale; Michelle B Titunick; Jessica M Biegler; Jessie L Reed; Alyssa M Hartung; David F Wiemer; Patricia J McLaughlin; Jeffrey D Neighbors
Journal:  Bioorg Med Chem       Date:  2017-06-27       Impact factor: 3.641

3.  Design, Synthesis, and Biological Evaluation of the Third Generation 17-Cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6β-[(4'-pyridyl)carboxamido]morphinan (NAP) Derivatives as μ/κ Opioid Receptor Dual Selective Ligands.

Authors:  Yi Zheng; Samuel Obeng; Huiqun Wang; Abdulmajeed M Jali; Bharath Peddibhotla; Dwight A Williams; Chuanchun Zou; David L Stevens; William L Dewey; Hamid I Akbarali; Dana E Selley; Yan Zhang
Journal:  J Med Chem       Date:  2019-01-11       Impact factor: 7.446

4.  Multiscale design of coarse-grained elastic network-based potentials for the μ opioid receptor.

Authors:  Mathieu Fossépré; Laurence Leherte; Aatto Laaksonen; Daniel P Vercauteren
Journal:  J Mol Model       Date:  2016-08-26       Impact factor: 1.810

5.  Molecular basis for high affinity and selectivity of peptide antagonist, Bantag-1, for the orphan BB3 receptor.

Authors:  Taichi Nakamura; Irene Ramos-Álvarez; Tatiana Iordanskaia; Paola Moreno; Samuel A Mantey; R T Jensen
Journal:  Biochem Pharmacol       Date:  2016-06-23       Impact factor: 5.858

Review 6.  Hitchhiking on the heptahelical highway: structure and function of 7TM receptor complexes.

Authors:  John J G Tesmer
Journal:  Nat Rev Mol Cell Biol       Date:  2016-04-20       Impact factor: 94.444

7.  Synthesis and Pharmacology of a Novel μ-δ Opioid Receptor Heteromer-Selective Agonist Based on the Carfentanyl Template.

Authors:  Abdelfattah Faouzi; Rajendra Uprety; Ivone Gomes; Nicolas Massaly; Attila I Keresztes; Valerie Le Rouzic; Achla Gupta; Tiffany Zhang; Hye Jean Yoon; Michael Ansonoff; Abdullah Allaoa; Ying Xian Pan; John Pintar; Jose A Morón; John M Streicher; Lakshmi A Devi; Susruta Majumdar
Journal:  J Med Chem       Date:  2020-11-10       Impact factor: 7.446

8.  Methylation Products of 6β- N-Heterocyclic Substituted Naltrexamine Derivatives as Potential Peripheral Opioid Receptor Modulators.

Authors:  Yi Zheng; Samuel Obeng; Huiqun Wang; David L Stevens; Essie Komla; Dana E Selley; William L Dewey; Hamid I Akbarali; Yan Zhang
Journal:  ACS Chem Neurosci       Date:  2018-07-23       Impact factor: 4.418

9.  Synergistic antihyperalgesic and antinociceptive effects of morphine and methyl 8-ethynyl-6-(pyridin-2-yl)-4H-benzo[f]imidazo[1,5-a][1,4]diazepine-3-carboxylate (MP-III-024): a positive allosteric modulator at α2GABAA and α3GABAA receptors.

Authors:  Mohammad A Rahman; Thomas M Keck; Michael M Poe; Dishary Sharmin; James M Cook; Bradford D Fischer
Journal:  Psychopharmacology (Berl)       Date:  2021-02-13       Impact factor: 4.415

10.  Computational Methods for Understanding the Selectivity and Signal Transduction Mechanism of Aminomethyl Tetrahydronaphthalene to Opioid Receptors.

Authors:  Peng Xie; Junjie Zhang; Baiyu Chen; Xinwei Li; Wenbo Zhang; Mengdan Zhu; Wei Li; Jianqi Li; Wei Fu
Journal:  Molecules       Date:  2022-03-28       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.